Logo image of SPXC

SPX TECHNOLOGIES INC (SPXC) Stock Fundamental Analysis

NYSE:SPXC - New York Stock Exchange, Inc. - US78473E1038 - Common Stock - Currency: USD

180.24  -0.18 (-0.1%)

After market: 180.24 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SPXC. SPXC was compared to 127 industry peers in the Machinery industry. SPXC has an excellent profitability rating, but there are concerns on its financial health. SPXC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

SPXC had positive earnings in the past year.
In the past 5 years SPXC has always been profitable.
SPXC had a positive operating cash flow in 4 of the past 5 years.
SPXC Yearly Net Income VS EBIT VS OCF VS FCFSPXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 6.46%, SPXC is doing good in the industry, outperforming 62.99% of the companies in the same industry.
SPXC has a better Return On Equity (14.04%) than 66.93% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.04%, SPXC is in the better half of the industry, outperforming 61.42% of the companies in the same industry.
SPXC had an Average Return On Invested Capital over the past 3 years of 7.42%. This is below the industry average of 10.90%.
The 3 year average ROIC (7.42%) for SPXC is below the current ROIC(9.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.46%
ROE 14.04%
ROIC 9.04%
ROA(3y)3.69%
ROA(5y)6.3%
ROE(3y)7.34%
ROE(5y)15.21%
ROIC(3y)7.42%
ROIC(5y)6.2%
SPXC Yearly ROA, ROE, ROICSPXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

SPXC's Profit Margin of 10.13% is fine compared to the rest of the industry. SPXC outperforms 69.29% of its industry peers.
In the last couple of years the Profit Margin of SPXC has grown nicely.
The Operating Margin of SPXC (15.66%) is better than 74.80% of its industry peers.
SPXC's Operating Margin has improved in the last couple of years.
SPXC has a better Gross Margin (40.59%) than 74.02% of its industry peers.
In the last couple of years the Gross Margin of SPXC has grown nicely.
Industry RankSector Rank
OM 15.66%
PM (TTM) 10.13%
GM 40.59%
OM growth 3Y33.6%
OM growth 5Y16.47%
PM growth 3Y-33.83%
PM growth 5Y16.81%
GM growth 3Y4.4%
GM growth 5Y6.86%
SPXC Yearly Profit, Operating, Gross MarginsSPXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SPXC is destroying value.
Compared to 1 year ago, SPXC has more shares outstanding
The number of shares outstanding for SPXC has been increased compared to 5 years ago.
The debt/assets ratio for SPXC has been reduced compared to a year ago.
SPXC Yearly Shares OutstandingSPXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SPXC Yearly Total Debt VS Total AssetsSPXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 4.24 indicates that SPXC is not in any danger for bankruptcy at the moment.
SPXC has a Altman-Z score of 4.24. This is in the better half of the industry: SPXC outperforms 67.72% of its industry peers.
SPXC has a Debt/Equity ratio of 0.65. This is a neutral value indicating SPXC is somewhat dependend on debt financing.
SPXC has a Debt to Equity ratio of 0.65. This is in the lower half of the industry: SPXC underperforms 65.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z 4.24
ROIC/WACC0.91
WACC9.91%
SPXC Yearly LT Debt VS Equity VS FCFSPXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

SPXC has a Current Ratio of 1.88. This is a normal value and indicates that SPXC is financially healthy and should not expect problems in meeting its short term obligations.
SPXC has a Current ratio of 1.88. This is comparable to the rest of the industry: SPXC outperforms 41.73% of its industry peers.
A Quick Ratio of 1.24 indicates that SPXC should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.24, SPXC perfoms like the industry average, outperforming 50.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.24
SPXC Yearly Current Assets VS Current LiabilitesSPXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

SPXC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.38%, which is quite impressive.
SPXC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.24% yearly.
Looking at the last year, SPXC shows a quite strong growth in Revenue. The Revenue has grown by 13.94% in the last year.
Measured over the past years, SPXC shows a small growth in Revenue. The Revenue has been growing by 5.40% on average per year.
EPS 1Y (TTM)23.38%
EPS 3Y31.31%
EPS 5Y15.24%
EPS Q2Q%10.4%
Revenue 1Y (TTM)13.94%
Revenue growth 3Y17.61%
Revenue growth 5Y5.4%
Sales Q2Q%3.74%

3.2 Future

SPXC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.43% yearly.
SPXC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.39% yearly.
EPS Next Y15.39%
EPS Next 2Y13.7%
EPS Next 3Y15.21%
EPS Next 5Y13.43%
Revenue Next Year11.82%
Revenue Next 2Y9.38%
Revenue Next 3Y8.29%
Revenue Next 5Y8.39%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SPXC Yearly Revenue VS EstimatesSPXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
SPXC Yearly EPS VS EstimatesSPXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.62, SPXC can be considered very expensive at the moment.
Based on the Price/Earnings ratio, SPXC is valued a bit more expensive than 63.78% of the companies in the same industry.
SPXC's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.91.
Based on the Price/Forward Earnings ratio of 25.03, the valuation of SPXC can be described as expensive.
Based on the Price/Forward Earnings ratio, SPXC is valued a bit more expensive than the industry average as 60.63% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 37.11. SPXC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 31.62
Fwd PE 25.03
SPXC Price Earnings VS Forward Price EarningsSPXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SPXC is valued a bit more expensive than 66.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.57
SPXC Per share dataSPXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SPXC does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SPXC may justify a higher PE ratio.
SPXC's earnings are expected to grow with 15.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.05
PEG (5Y)2.07
EPS Next 2Y13.7%
EPS Next 3Y15.21%

0

5. Dividend

5.1 Amount

No dividends for SPXC!.
Industry RankSector Rank
Dividend Yield N/A

SPX TECHNOLOGIES INC

NYSE:SPXC (7/29/2025, 8:21:16 PM)

After market: 180.24 0 (0%)

180.24

-0.18 (-0.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners94.98%
Inst Owner Change-0.66%
Ins Owners3.24%
Ins Owner Change7.56%
Market Cap8.42B
Analysts87.69
Price Target189.92 (5.37%)
Short Float %2.15%
Short Ratio4.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.73%
Min EPS beat(2)-1.85%
Max EPS beat(2)15.31%
EPS beat(4)3
Avg EPS beat(4)6.29%
Min EPS beat(4)-1.85%
Max EPS beat(4)15.31%
EPS beat(8)6
Avg EPS beat(8)8.98%
EPS beat(12)10
Avg EPS beat(12)14.23%
EPS beat(16)13
Avg EPS beat(16)11.37%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-1.83%
Max Revenue beat(2)-1.78%
Revenue beat(4)0
Avg Revenue beat(4)-2.26%
Min Revenue beat(4)-5.31%
Max Revenue beat(4)-0.12%
Revenue beat(8)3
Avg Revenue beat(8)-0.87%
Revenue beat(12)7
Avg Revenue beat(12)1.46%
Revenue beat(16)7
Avg Revenue beat(16)0.38%
PT rev (1m)6.3%
PT rev (3m)13.26%
EPS NQ rev (1m)-0.26%
EPS NQ rev (3m)-5.45%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)2.71%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)0.67%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)2.49%
Valuation
Industry RankSector Rank
PE 31.62
Fwd PE 25.03
P/S 4.21
P/FCF N/A
P/OCF N/A
P/B 5.83
P/tB N/A
EV/EBITDA 22.57
EPS(TTM)5.7
EY3.16%
EPS(NY)7.2
Fwd EY4%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS42.85
BVpS30.9
TBVpS-7.72
PEG (NY)2.05
PEG (5Y)2.07
Profitability
Industry RankSector Rank
ROA 6.46%
ROE 14.04%
ROCE 11.81%
ROIC 9.04%
ROICexc 9.68%
ROICexgc 33.47%
OM 15.66%
PM (TTM) 10.13%
GM 40.59%
FCFM N/A
ROA(3y)3.69%
ROA(5y)6.3%
ROE(3y)7.34%
ROE(5y)15.21%
ROIC(3y)7.42%
ROIC(5y)6.2%
ROICexc(3y)7.93%
ROICexc(5y)6.67%
ROICexgc(3y)26.34%
ROICexgc(5y)19.42%
ROCE(3y)9.52%
ROCE(5y)8.03%
ROICexcg growth 3Y80.68%
ROICexcg growth 5Y32.98%
ROICexc growth 3Y48.19%
ROICexc growth 5Y15.92%
OM growth 3Y33.6%
OM growth 5Y16.47%
PM growth 3Y-33.83%
PM growth 5Y16.81%
GM growth 3Y4.4%
GM growth 5Y6.86%
F-ScoreN/A
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA 2.3
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.24
Altman-Z 4.24
F-ScoreN/A
WACC9.91%
ROIC/WACC0.91
Cap/Depr(3y)37.86%
Cap/Depr(5y)37.56%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.38%
EPS 3Y31.31%
EPS 5Y15.24%
EPS Q2Q%10.4%
EPS Next Y15.39%
EPS Next 2Y13.7%
EPS Next 3Y15.21%
EPS Next 5Y13.43%
Revenue 1Y (TTM)13.94%
Revenue growth 3Y17.61%
Revenue growth 5Y5.4%
Sales Q2Q%3.74%
Revenue Next Year11.82%
Revenue Next 2Y9.38%
Revenue Next 3Y8.29%
Revenue Next 5Y8.39%
EBIT growth 1Y40.05%
EBIT growth 3Y57.13%
EBIT growth 5Y22.75%
EBIT Next Year29.82%
EBIT Next 3Y14.68%
EBIT Next 5Y15.57%
FCF growth 1Y34.29%
FCF growth 3Y14.53%
FCF growth 5Y13.64%
OCF growth 1Y37.12%
OCF growth 3Y17.87%
OCF growth 5Y13.98%